NCT03384745 - A Phase 2b Study of the Efficacy, Safety, and Tolerability of M1095 (Sonelokimab) in Subjects With Moderate to Severe Psoriasis | Biotech Hunter

Enrollment

313

Participants

Timeline

Start Date

July 31, 2018

Primary Completion Date

June 20, 2019

Study Completion Date

March 26, 2020

Conditions

Psoriasis

Interventions

DRUG

M1095 (Sonelokimab)

M1095 (Sonelokimab) is a trivalent monomeric nanobody® that neutralizes interleukins IL-17A, IL-17F, and IL-17A/F.

DRUG

Placebo

Placebo contains no active drug.

DRUG

Secukinumab

Secukinumab is a human immunoglobulin G1 (IgG1) monoclonal antibody that selectively binds IL-17A.

Trial Locations (60)

1085

Investigative Site, Budapest

1135

Investigative Site, Budapest

1431

Investigative Site, Sofia

2600

Investigative Site, Dupnitsa

5000

Investigative Site, Szolnok

5900

Investigative Site, Orosháza

6000

Investigative Site, Kecskemét

6720

Investigative Site, Szeged

9010

Investigative Site, Varna

10029

Investigative Site, New York

10789

Investigative Site, Berlin

15831

Investigative Site, Mahlow

19055

Investigative Site, Schwerin

20354

Investigative Site, Hamburg

24105

Investigative Site, Kiel

30328

Investigative Site, Sandy Springs

32720

Investigative Site, DeLand

35205

Investigative Site, Birmingham

43209

Investigative Site, Bexley

44793

Investigative Site, Bochum

49074

Investigative Site, Osnabrück

55131

Investigative Site, Mainz

60590

Investigative Site, Frankfurt am Main

63117

Investigative Site, St Louis

64297

Investigative Site, Darmstadt

75246

Investigative Site, Dallas

77004

Investigative Site, Houston

78229

Investigative Site, San Antonio

86179

Investigative Site, Augsburg

87102

Investigative Site, Albuquerque

88045

Investigative Site, Friedrichshafen

92123

Investigative Site, San Diego

T5K 1X3

Investigative Site, Edmonton

V3R 6A7

Investigative Site, Surrey

V3V 0C6

Investigative Site, Surrey

L3P 1X2

Investigative Site, Markham

P1B 3Z7

Investigative Site, North Bay

L6J 7W5

Investigative Site, Oakville

K2G 6E2

Investigative Site, Ottawa

L4B 1A5

Investigative Site, Richmond Hill

N2J 1C4

Investigative Site, Waterloo

N8W 1E6

Investigative Site, Windsor

G1V 4X7

Investigative Site, Québec

602 00

Investigative Site, Brno

547 01

Investigative Site, Náchod

741 01

Investigative Site, Nový Jičín

702 00

Investigative Site, Ostrava

708 52

Investigative Site, Ostrava

530 02

Investigative Site, Pardubice

130 00

Investigative Site, Prague

686 01

Investigative Site, Uherské Hradiště

06484

Investigative Site, Quedlinburg

40-060

Investigative Site, Katowice

20-314

Investigative Site, Lublin

60-848

Investigative Site, Poznan

08-110

Investigative Site, Siedlce

96-100

Investigative Site, Skierniewice

02-507

Investigative Site, Warsaw

02-777

Investigative Site, Warsaw

04-141

Investigative Site, Warsaw